title: Selecting promising ALS therapies in clinical trials.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Glass
authors.forename: Michael
authors.initials: M
authors.lastname: Benatar
authors.forename: Meraida
authors.initials: M
authors.lastname: Polak
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic / Q000592:standards*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods / Q000592:standards*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics / Q000378:metabolism; D018696:Neuroprotective Agents / Q000493:pharmacokinetics; D018579:Patient Selection
chemical_list: D018696:Neuroprotective Agents